Allopurinol Outcome Study

PHASE4CompletedINTERVENTIONAL
Enrollment

1,735

Participants

Timeline

Start Date

July 31, 2011

Primary Completion Date

January 31, 2013

Study Completion Date

March 31, 2013

Conditions
Gout
Interventions
DRUG

Allopurinol

Commercially available allopurinol 100 mg and 300 mg oral tablets will be prescribed by the Investigator according to the approved product label.

Trial Locations (173)

1010

Auckland

1070

Brussels

1724

Johannesburg

2000

Pretoria

2050

Camperdown

2113

Johannesburg

2522

Wollongong

2525

Papatoetoe

3010

Rotorua

3081

Heidelberg

3110

Tauranga

3168

Clayton

3240

Hamilton

3353

North Ballarat

4037

Durban

4067

Durban

4092

Durban

4152

Birsbane

5011

Woodville South

5041

Daw Park

5201

East London

5530

Yvoir

6000

Perth

6534

Gozée

6850

Worcester

7000

Hobart

7600

Stellenbosch

7646

Paarl

7700

Mouscron

Rondebosch

8024

Christchurch

8500

Kortrijk

9301

Bloemfontein

10530

Hartsdale

12206

Albany

13760

Endwell

16602

Altoona

16635

Duncansville

17601

Lancaster

20902

Wheaton

21502

Cumberland

21702

Frederick

21740

Hagerstown

22205

Arlington

23294

Richmond

26505

Morgantown

27609

Raleigh

27612

Raleigh

28075

Harrisburg

28210

Charlotte

28401

Wilmington

28602

Hickory

29303

Spartanburg

29407

Charleston

29464

Mt. Pleasant

30265

Newnan

30308

Atlanta

32003

Fleming Island

32127

Port Orange

32174

Ormond Beach

32205

Jacksonville

32216

Jacksonville

32771

Sanford

32804

Orlando

32960

Vero Beach

33135

Miami

33458

Jupiter

33511

Brandon

33542

Zephyrhills

33563

Plant City

33606

Tampa

33709

St. Petersburg

33880

Winter Haven

34208

Brandenton

East Brandenton

34601

Brooksville

34677

Oldsmar

35040

Calera

35216

Bringham

35242

Birmingham

35294

Birmingham

35801

Huntsville

36608

Mobile

37174

Spring Hill

38305

Jackson

38654

Olive Branch

40213

Louisville

40504

Lexington

42701

Elizabethtown

43203

Columbus

44122

Cleveland

44130

Middleburg Heights

45224

Cincinnati

45242

Cincinnati

45417

Dayton

47713

Evansville

49684

South Traverse City

55905

Rochester

58103

Fargo

60031

Gurnee

60101

Addison

60612

Chicago

60637

Chicago

63031

Florissant

63117

St Louis

63128

St Louis

64114

Kansas City

68114

Omaha

71203

Monroe

72204

Little Rock

72205

Little Rock

72401

Jonesboro

73103

Oklahoma City

75061

Irving

75150

Mesquite

75216

Dallas

75235

Dallas

77074

Houston

77088

Houston

77479

Sugar Land

78229

San Antonio

80113

Englewood

80220

Denver

83646

Meridian

84010

Bountiful

84088

West Jordan

85028

Phoenix

85050

Phoenix

85072

Eichstätt

85224

Chandlers

85614

Green Valley

85704

Tucson

87102

Albuquerque

87106

Albuquerque

89119

Las Vegas

89502

Reno

90048

Los Angeles

91107

Pasadena

91361

Weslake Village

91723

Covina

92108

San Diego

92543

Hemet

92618

Irvine

92691

Mission Viejo

92805

Anaheim

93454

Santa Maria

94583

San Ramon

95608

Carmichael

95816

Sacramento

96814

Honolulu

97220

Portland

97402

Eugene

98122

Seattle

98366

Port Orchard

98405

Tacoma

99208

Spokane

06810

Danbury

06611

Trumbull

02601

Hyannis

01605

Worcester

03060

Nashua

VIC3145

Malvern East

V3K 3P4

Coquitlam

V1Y 3G8

Kelowna

V2A 5C8

Penticton

K1S 1L2

Ottawa

L4J 1W3

Thornhill

M9W 4L6

Toronto

G1V 3M7

Québec

04600

Altenburg

01307

Dresden

0084

Pretoria

0380

Thabazimbi

Sponsors
All Listed Sponsors
lead

Ardea Biosciences, Inc.

INDUSTRY

NCT01391325 - Allopurinol Outcome Study | Biotech Hunter | Biotech Hunter